Cite
MLA Citation
Marco Gattorno et al.. “Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study.” Annals of the rheumatic diseases, vol. 76, no. 1, 2017, pp. 173–178. http://access.bl.uk/ark:/81055/vdc_100137791535.0x00005a